Parallel Session 2.4
- Overview of the European Healthcare Lighthouse initiative,
BigMedilytics - Dr Supriyo Chatterjea (Philips)
- Role of Big Data in Oncology/Prostate cancer
- Optimizing the care of kidney transplant patients using Big Data
- Role of Big Data in Population Health
- GDPR, Big Data and Healthcare - Prof. Ricard Martínez (Incliva)
- Questions & Answers
A Healthy nation is a Wealthy nation! An improvement in health leads to economic growth through long-term gains in human and physical capital, which ultimately raises productivity and per capita GDP. However, the healthcare sector is highly cost-intensive and currently accounts for 10% of the EU’s GDP. In 2014 the EU-28’s total healthcare expenditure was €1.39 trillion. This is expected to increase to 30% by 2060. The increase in healthcare costs is primarily due to a rapidly ageing population. In fact, chronic diseases result in the loss of 3.4 million potential productive life years. This amounts to an annual loss of €115 billion for EU economies. These figures clearly indicate that current trends within the Healthcare sector are totally unsustainable. The BigMedilytics Healthcare Lighthouse project aims to demonstrate how the use of Big Data technologies can help disrupt the Healthcare sector so that the quality, cost and access to care can all be improved - simultaneously.
The project executes a total of 12 pilots covering three main themes: Population Health, Oncology and Industrialization of Healthcare. This talk will give an overview of some of the pilots being executed under the Population Health and Oncology themes. Clinical experts will describe the problems they face and why a Big Data approach is needed while technology specialists will provide an overview of the Big Data solutions being developed for the various pilots. To deal with the sensitivity of patient data, the session will also include a talk describing the impact of GDPR on the healthcare sector and steps needed to ensure the sector benefits from the power of Big Data analytics while preserving the privacy of individuals.
Dr Supriyo Chatterjea
Data Science Department, Philips
Dr Supriyo Chatterjea is the coordinator of the BigMedilytics Healthcare Lighthouse project and a Senior Scientist at the Data Science Department at Philips. He joined Philips in 2008 and originally led multiple projects on communication technologies for large-scale, self-organizing IoT networks for smart city applications. He subsequently moved to the Data Science department within Philips where he was involved in using machine learning algorithms for a diverse set of applications ranging from gathering insights from data generated by large-scale IoT networks to the identification of disease biomarkers. He currently drives multiple initiatives where machine learning algorithms are used to optimize workflows in hospitals, using a combination of real-time locating systems, hospital IT systems and other internet-of-medical-things (IoMT), to ensure hospitals achieve the Quadruple Aim by improving Patient Experience, Population Health, Cost of Care and Provider Well-Being simultaneously. Prior to joining Philips, he was a post-doctoral researcher at the University of Twente focusing on designing communication protocols for wireless industrial monitoring and control and zero-energy buildings. He received his PhD and MSc in Computer Science from the University of Twente and King’s College London respectively.
Prof. Dr Olof Akre
Hospital Research Group Leader, Urology, Karolinska Institute
Prof. Dr Olof Akre is a professor of epidemiology and senior consultant urologist specialized on robotic prostate-cancer surgery. He is the Patient-Flow Captain for the entire prostate-cancer care flow at Karolinska University Hospital. He also has a long publication list from a large number of clinical epidemiologic studies of urologic tumours using nationwide databases, medical charts, and biological samples, etc. He was previously the lead clinician at the Urology Dept. of Karolinska University Hospital and is the scientific secretary of the Swedish Urology Association. He is a member of the steering committee of the National Prostate Cancer Register and the Principal investigator for SPCG-15 – a large Scandinavian randomized control trial of primary surgery vs primary radiotherapy for locally advanced prostate cancer.
Dr Ralf Hoffmann
Dr Ralf Hoffmann is Principal at Philips Research in Eindhoven, The Netherlands. He holds a PhD in Protein Biochemistry and Molecular Biology and an MSc in Biology from the University of Constance, Germany. After his time as a Postdoc at the University of Constance and at the University Hospital in Ulm, Germany, he moved to Sandoz Pharma, Basel, Switzerland to analyse the function and regulation of phosphodiesterases in inflammatory processes associated with asthma. After the merger between Sandoz Pharma and Ciba Geigy, he was working on target discovery for therapeutic applications in the field of Neuroscience. In 1998, Ralf left Novartis to build and lead a team performing high-throughput discovery of therapeutic targets for neurological diseases at Biofrontera Pharmaceuticals, Leverkusen, a German biotech start-up. He became a Director of Technology development and took over responsibility to develop a high-throughput expression data analysis platform to automatically analyse large-scale qPCR data for quality aspects and disease-relevant gene expression signatures. In 2003, he joined Philips Research in Germany, as a Principal Scientist responsible for the development of opportunities in the area of Molecular Diagnostics and Molecular Imaging. In 2004, he moved to Philips Research in Eindhoven to establish a project aiming at the identification of novel biomarkers for the diagnosis and prognosis of cancer diseases, in particular prostate cancer. As a PI of the prostate cancer biomarker activity at Philips, he was responsible for a number of external clinical and academic prostate cancer related collaborations on the European level. He was appointed honorary Senior Lecturer (Associated Professor) at Glasgow University in 2009 due to his substantial role in supervision of several Philips-BBSRC funded PhD students.
Dr Wiebke Düttmann-Rehnolt
Dr. med. univ. Wiebke Düttmann-Rehnolt is a member of° the Department of Nephrology and Internal Intensive Care at Charité-Universitätsmedizin Berlin. She studied Medicine at Medical University of Graz, Austria and accomplished a Doctoral Study afterwards. She started the training as internal medicine resident in Graz and is continuing it at Charité. Since June of 2018, she works on the EU Project Big Medilytics.
Dr Roland Roller
Data Science Department, Philips
Dr Roland Roller is a researcher and project manager in the language technology group at the German Research Center for Artificial Intelligence (DFKI). He studied Computer Science in Trier and Saarland University and completed his PhD at the University of Sheffield. His research interests are in the field of natural language processing and machine learning with a particular focus on the biomedical domain. Currently, he is working on information extraction and clinical decision support in the context of kidney disease within the two research projects MACSS (Medical Allround-Care Service Solutions) and BigMedilytics (Big Data for Medical Analytics).
Prof. Dr Josep Redon
Prof. Dr Josep Redon graduated in 1974 in Medicine at the University of Valencia and specialized in internal medicine at the Jiménez Díaz Foundation in Madrid and at the Hospital Universitario La Fe of Valencia. He moved to the United States in 1991 to focus their research on hypertension, first at Northwestern University in Chicago and later on at the Loyola University of Illinois. He has been Professor of Medicine at the University of Valencia for more than two decades, Head of Internal Medicine at the Valencia University Clinic Hospital and Scientific Director at the Incliva Health Research Institute. Member since its foundation of the European Society of Hypertension, Prof Redón belongs to its board of directors since 2005 and has been its president until June 2013.
Between 2000 and 2004 chaired the Spanish Society of Hypertension. Currently, he's evaluator of the National Agency for Evaluation and Prospective (ANECA) and member of the Steering Committee for the Cardiovascular Disease Prevention Plan, of the Valencian Department of Health and Consumer Affairs of the Valencian Government. He is also Doctor Honoris Causa from the Carol Davila University of Medicine and Pharmacology, Bucharest (Romania), has authored numerous papers (more than 300 in JRC), is Associate Editor of the Journal of Hypertension (1Q) and member of the Editorial Board for several journals in the field of hypertension such as Hypertension, Journal of Hypertension or Blood Pressure Monitoring.
Marija joined Philips Research in 2016 to work as a Research Scientist within the Data Science Department. Marija’s work is mainly focused on algorithm design and software programming in various applications within the domain of AI in Healthcare. Since 2016, Marija is the Healthcare taskforce lead within Big Data Value Association (BDVA). Before joining Philips Research, Marija worked as a visiting researcher in Philips Lighting (Signify) on context-aware lighting applications with the aim of simultaneous comfort improvement and energy preservation. She has several years of experience as a Lead Project Engineer in the domain of Smart Buildings.
Prof. Dr Ricard Martínez
Prof. dr. Ricard Martínez has a Doctor in Law from the Universitat de València. He has dedicated his research to study fundamental laws concerning data protection and also different issues related to the effects of information and communication technologies and the private life. He is currently an Assistant Professor Doctor in the Department of Constitutional Law, Political and Administrative Sciences of the Universitat de Valencia. He is included in the Work Group concerning Digital Rights of Citizens of the Ministry of Energy, Tourism and Digital Agenda. He coordinates the Work Group constituted by the Principals’ Conference of Spanish Universities (CRUE-TIC) for the boost of the General Regulation of data protection. He has worked as a delegate of data protection in the Universitat de València and has been head of the Transparency Service of the Valencian Provincial Council and President of the Professional Spanish Association of Privacy. He has collaborated with different universities as a Professor in Degree and Postgraduate Studies and has been responsible for the Studies Area of the Spanish Agency of Data Protection. He has written different monographies dedicated to this issue, -"Tecnologías de la Información, Policía y Constitución", "Una aproximación crítica a la autodeterminación informativa”- and has participated as an author and coordinator in different comments to the Development Regulation of the Organic Law of Data protection, and monographies about Law and Social Networks or Cloud Computing among others. He is a member of the Academic Council of Fide and co-director of its Data Protection Forum.